The Stark Reality of Cervical Cancer in Argentina

Cervical cancer remains a significant health challenge for women in Argentina. As the third most common cancer and the second leading cause of gynecological cancer deaths, it underscores critical gaps in prevention, early detection, and treatment accessibility. World Cervical Cancer Day, observed every March 26th, serves as a crucial reminder of the need to address this pervasive issue.

HPV: The Primary Culprit

The scientific consensus firmly establishes the Human Papillomavirus (HPV) as the primary risk factor for cervical cancer. Certain high-risk HPV subtypes, especially 16 and 18, are implicated in approximately 70% of cervical cancer cases. Other subtypes, including 31, 33, 35, 45, 52, and 58, also contribute considerably, accounting for 20% of invasive carcinomas and appearing in 30-40% of low- and high-grade lesions.

Transmission of HPV primarily occurs through sexual contact, but it can also spread via skin-to-skin contact in the genital area. This highlights the limitations of condoms as a sole method of prevention. As Dr.Veronica Fabiano, gynecologist and mastologist at the Alexander Fleming institute (IAF) notes:

Infection can also be skin by skin in sexual contacts, so the condom may not prevent. Likewise, it is indeed crucial to use it to avoid other types of sexually transmitted diseases such as HIV, hepatitis B and C, and gonorrhea; and unplanned pregnancies.
Dr. Veronica Fabiano,Alexander Fleming Institute (IAF)

The Role of the Immune System and Risk Factors

While an estimated 70% to 80% of individuals will encounter an HPV variant during their lifetime,only a small fraction will develop cervical cancer. In most instances, the immune system effectively clears the infection without lasting consequences. Dr. Ana Laura Mendaña, a clinical oncologist at the IAF, explains:

Only some women with persistent infections and high-grade injuries will develop cervical cancer.
Dr. Ana Laura Mendaña, Alexander Fleming institute (IAF)

However, the risk of progression increases with factors such as early onset of sexual activity, lack of HPV vaccination, immunodeficiency, and socioeconomic conditions that impede access to regular medical check-ups. Consequently, a common and frequently enough transient infection can evolve into a severe cancer process when effective preventive measures are lacking.

Territorial Disparities: A Matter of Access

A particularly concerning aspect of cervical cancer in Argentina is the significant territorial inequality in incidence and mortality rates. The northeastern provinces, including Formosa, Misiones, and Chaco, exhibit the highest figures, while the City of Buenos Aires, Tierra del Fuego, and Santa Cruz report the lowest. This disparity reflects profound differences in access to healthcare services, hospital infrastructure, and prevention programs.

In many high-mortality areas,systematic detection programs are either absent or inaccessible due to geographical,cultural,or economic barriers. The lack of consistent awareness campaigns, a shortage of trained healthcare professionals, and difficulties in scheduling medical appointments further perpetuate this inequity. The fragmented distribution of healthcare resources and policies hinders a unified response to a disease that is largely preventable with thorough and sustained strategies.

Addressing the Challenge: A Call to Action

Guaranteeing equitable access to HPV vaccination, regular screenings, and timely treatment, nonetheless of geographic location, is an urgent priority to reduce the burden of cervical cancer in Argentina. A concerted effort involving government agencies, healthcare providers, and community organizations is essential to implement effective prevention and control programs, ultimately saving lives and reducing health disparities.